NEW YORK (GenomeWeb News) – Shares in Beckman Coulter were down approximately 7.7 percent, or $4.39, at $52.61 in mid-afternoon trading today after the company reported a decrease in second-quarter sales and net income.
As reported by GenomeWeb News this morning, total revenues declined to $616 million, from $619 in the same period last year. Beckman blamed the lower-than-expected revenues on lagging sales in the Asian market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.